Patent · US Active

Low, immune enhancing, dose MTOR inhibitors and uses thereof

US10286069B2 · kind B2 · utility

8Cited by
1References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 25, 2018
Grant dateMay 14, 2019
Priority date—
Expiry dateJun 25, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2760/16034
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates, in part, to compositions and methods for enhancement of an immune response by partial mTOR inhibition, e.g., with low, immune enhancing, doses of an mTOR inhibitor, such as RAD001.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.